202 related articles for article (PubMed ID: 38031784)
1. Current Perspectives of Immunotherapy for Hepatocellular Carcinoma.
Liu X; Lei X; Huang S; Yang X
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 38031784
[TBL] [Abstract][Full Text] [Related]
2. [Research progress of immunotherapy alone and in combination for liver cancer].
Wu ZJL; Li K; Zhang K; Gong WD
Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):471-474. PubMed ID: 32660173
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.
Liu X; Qin S
Oncologist; 2019 Feb; 24(Suppl 1):S3-S10. PubMed ID: 30819826
[TBL] [Abstract][Full Text] [Related]
4. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
5. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma.
Pourhamzeh M; Asadian S; Mirzaei H; Minaei A; Shahriari E; Shpichka A; Es HA; Timashev P; Hassan M; Vosough M
Mol Cell Biochem; 2023 Jan; 478(1):23-37. PubMed ID: 35708866
[TBL] [Abstract][Full Text] [Related]
6. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
Fu Y; Liu S; Zeng S; Shen H
J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease.
Cassese G; Han HS; Lee B; Lee HW; Cho JY; Panaro F; Troisi RI
World J Hepatol; 2022 Oct; 14(10):1862-1874. PubMed ID: 36340753
[TBL] [Abstract][Full Text] [Related]
8. [Progress in immunotherapy for hepatocellular carcinoma].
Shen Z; Li M; Bai S; Yang Q; Zhang F; Tang M; Guo J; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2326-2338. PubMed ID: 31880139
[TBL] [Abstract][Full Text] [Related]
9. PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy.
Li Q; Han J; Yang Y; Chen Y
Front Immunol; 2022; 13():1070961. PubMed ID: 36601120
[TBL] [Abstract][Full Text] [Related]
10. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives.
Mandlik DS; Mandlik SK; Choudhary HB
World J Gastroenterol; 2023 Feb; 29(6):1054-1075. PubMed ID: 36844141
[TBL] [Abstract][Full Text] [Related]
13. The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy.
Guizhen Z; Guanchang J; Liwen L; Huifen W; Zhigang R; Ranran S; Zujiang Y
Front Endocrinol (Lausanne); 2022; 13():918869. PubMed ID: 36093115
[TBL] [Abstract][Full Text] [Related]
14. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for hepatocellular carcinoma.
Zhou M; Liu B; Shen J
Clin Exp Med; 2023 Jul; 23(3):569-577. PubMed ID: 36001163
[TBL] [Abstract][Full Text] [Related]
16. Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review.
Reiter FP; Ben Khaled N; Ye L; Zhang C; Seidensticker M; Op den Winkel M; Denk G; Geier A; De Toni EN
Dig Dis; 2022; 40(5):565-580. PubMed ID: 34644705
[TBL] [Abstract][Full Text] [Related]
17. HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma.
Shen C; Li M; Duan Y; Jiang X; Hou X; Xue F; Zhang Y; Luo Y
Front Immunol; 2023; 14():1170207. PubMed ID: 37304265
[TBL] [Abstract][Full Text] [Related]
18. Engineering T cells for immunotherapy of primary human hepatocellular carcinoma.
Caraballo Galva LD; Cai L; Shao Y; He Y
J Genet Genomics; 2020 Jan; 47(1):1-15. PubMed ID: 32089500
[TBL] [Abstract][Full Text] [Related]
19. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
Kotsari M; Dimopoulou V; Koskinas J; Armakolas A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511228
[TBL] [Abstract][Full Text] [Related]
20. Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma.
Zhu Y; Qin LX
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):420-429. PubMed ID: 35977874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]